FVCB:NASDAQFVCBankcorp, Inc. Analysis
Data as of 2026-06-30 - not real-time
$17.46
Latest Price
4/10Risk
Risk Level: Medium
Executive Summary
FVCBankcorp shows a bullish technical backdrop with a moving‑average alignment that sits comfortably above short‑term averages, a bullish MACD crossover, and momentum indicators flirting with overbought territory. Price action remains above key support while testing a nearby resistance level, suggesting limited downside and potential for a short‑run breakout. Fundamentally, the bank delivers strong operating margins, healthy earnings per share growth, and a modest dividend that is well‑covered by cash flow and a low payout ratio.
The valuation picture is compelling: the market price trails a discounted cash‑flow estimate by a wide margin, and the price‑to‑earnings multiple sits below the industry average, flagging an attractive entry point. With a solid balance sheet, minimal leverage, and a low beta, the stock presents a low‑to‑moderate risk profile, making it a candidate for investors seeking both income and upside potential.
The valuation picture is compelling: the market price trails a discounted cash‑flow estimate by a wide margin, and the price‑to‑earnings multiple sits below the industry average, flagging an attractive entry point. With a solid balance sheet, minimal leverage, and a low beta, the stock presents a low‑to‑moderate risk profile, making it a candidate for investors seeking both income and upside potential.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD with supportive moving averages
- RSI approaching overbought levels
- Strong operating margin cushioning short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Significant undervaluation relative to DCF fair value
- Robust revenue growth and low leverage
- Sustainable dividend with low payout ratio
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Long‑run upside to intrinsic value estimate
- Consistent profitability and cash generation
- Stable regional banking niche with modest beta
Key Metrics & Analysis
Financial Health
Revenue Growth16.70%
Profit Margin34.03%
P/E Ratio13.6
ROE9.26%
ROA1.02%
P/B Ratio1.2
Op. Cash Flow$26.1M
Industry P/E16.9
Technical Analysis
TrendBullish
RSI69.9
Support$15.53
Resistance$17.75
MA 20$16.63
MA 50$16.04
MA 200$14.47
MACDBullish
VolumeDecreasing
Fear & Greed Index90.18
Valuation
Fair Value$36.02
Target Price$18.38
Upside/Downside5.24%
GradeUndervalued
TypeGrowth
Dividend Yield1.60%
Risk Assessment
Beta0.51
Volatility19.60%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.